BackANI Pharmaceuticals Overview

ANI Pharmaceuticals Operating Income

Operating Income for ANIP.

Quarterly Operating Income

$38.89M
↑ 48.46% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$137.19M
↑ 1910.18% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin